Vitruvias Therapeutics thyroid tablet recall: FDA issues serious Class I warning over ‘superpotent’ medicine — check lot number, expiration date and what patients should know
N
Nimisham EditorialSenior Editorial Lead
Nimisham
Source Attribution: View original report on Economic Times
